ArticleCurrent medicinal chemistry2025

FOXN3-AS1: A Candidate Prognostic Marker and Epigenetic Target with Immunotherapeutic Implications in Acute Myeloid Leukemia.

Fangfang Ge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.